Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement
Launched by UNIVERSITY OF MICHIGAN · Apr 19, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to help young people aged 14 to 24 who have been treated for injuries related to violence. The researchers want to see if two different kinds of remote therapy programs can reduce violent behavior and other related issues. One program is a standard version, while the other uses artificial intelligence to adapt the therapy to each person’s needs. The goal is to find effective ways to support young people, especially those from lower-income backgrounds, in overcoming violence and its consequences.
To be eligible for the study, participants need to have sought treatment in the emergency department for a violent injury, own a smartphone with texting and internet access, and understand English. Those who are experiencing severe mental health issues, are incarcerated, or are younger than 18 without a parent or guardian present cannot participate. If someone joins the trial, they will receive either of the two therapy programs remotely, with the aim of helping them develop healthier behaviors and reduce their involvement in violence. This research is important as it seeks to find better ways to provide support to at-risk youth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Youth will be eligible if they screen is positive for seeking treatment in the ED for a violent injury, age 14-24, and report ownership of a smartphone with texting capability and internet access.
- Exclusion Criteria:
- • Youth will be excluded if they do not understand English, cannot provide informed consent due to mental incompetence, incarceration or medical instability (unstable patients will be recruited if they stabilize within 72 hours), are 14-17 years old and presenting without an accessible parent/guardian, are presenting for suicide attempt/intent, sexual assault, and/or child abuse (due to high intensity of social services needed for such patients during their ED visit).
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Flint, Michigan, United States
Atlanta, Georgia, United States
Detroit, Michigan, United States
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials